English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1872]
News [4281]
Articles [400]
Editorials [10]
Conferences [107]
elearning [41]
Important developments in radiation oncology
Dr Ana Botero - Memorial Healthcare System, Hollywood, FL, USA
Important developments in radiation oncology ( Dr Ana Botero - Memorial Healthcare System, Hollywood, FL, USA )
26 Jul 2019
Latest updates in HER2-positive metastatic breast cancer: The NALA and SOPHIA...
Dr Connie Guaqueta - Memorial Cancer Institute, Miami, USA
Latest updates in HER2-positive metastatic breast cancer: The NALA and SOPHIA trials ( Dr Connie Guaqueta - Memorial Cancer Institute, Miami, USA )
26 Jul 2019
Implementing the Breast Health Global Initiative guidelines
Prof Benjamin Anderson
Implementing the Breast Health Global Initiative guidelines ( Prof Benjamin Anderson )
12 Jul 2019
Guidelines for prepectoral implant-based breast reconstruction
Dr Raghavan Vidya - Royal Wolverhampton Hospital, Wolverhampton, UK
Guidelines for prepectoral implant-based breast reconstruction ( Dr Raghavan Vidya - Royal Wolverhampton Hospital, Wolverhampton, UK )
11 Jul 2019
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast...
Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer ( Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan )
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019
PARP inhibitors olaparib and talazoparib as treatment for metastatic breast...
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
PARP inhibitors olaparib and talazoparib as treatment for metastatic breast cancer ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
18 Jun 2019
The potential of PARP inhibitors in new cancer groups and in combination with...
Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston...
The potential of PARP inhibitors in new cancer groups and in combination with other treatments ( Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston, USA )
18 Jun 2019
BYLieve study results: Alpelisib and endocrine therapy in patients with PIK3CA...
Prof Hope Rugo - University of California, San Francisco, USA
BYLieve study results: Alpelisib and endocrine therapy in patients with PIK3CA-mutated/HR /HER2- advanced breast cancer ( Prof Hope Rugo - University of California, San Francisco, USA )
12 Jun 2019
Advances in PARP inhibitor use for metastatic breast cancer
Prof Hope Rugo - University of California, San Francisco, USA
Advances in PARP inhibitor use for metastatic breast cancer ( Prof Hope Rugo - University of California, San Francisco, USA )
12 Jun 2019
Margetuximab for the treatment of HER2-positive breast cancer
Prof Debu Tripathy - The University of Texas MD Anderson Cancer Center, Houston...
Margetuximab for the treatment of HER2-positive breast cancer ( Prof Debu Tripathy - The University of Texas MD Anderson Cancer Center, Houston, USA )
12 Jun 2019
DORA: Using olaparib alone or with durvalumab in platinum responsive advanced...
Dr Tira Tan - National Cancer Centre, Singapore
DORA: Using olaparib alone or with durvalumab in platinum responsive advanced triple-negative breast cancer ( Dr Tira Tan - National Cancer Centre, Singapore )
12 Jun 2019
<1...5354555657...156>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top